IPOs
-
Generate Biomedicines’ $400M IPO Puts AI Drug Discovery Back in Focus
Generate Biomedicines priced its U.S. initial public offering on February 26, 2026, selling 25 million shares at $16 each for…
Read More » -
IPO News – US IPO Week Ahead: Medtronic carve-out MiniMed to kick-off March activity
Two IPOs are currently scheduled in the week ahead, although some smaller issuers may join the calendar throughout…
Read More » -
Rentberry Dominates PropTech Landscape with World’s First End-to-End AI Rental Ecosystem; Announces $20M Pre-IPO Round and NASDAQ Ticker ‘RNTB’
United States, February 27, 2026 — Rentberry, the global leader in rental technology, today announced a massive expansion of its…
Read More » -
Figure Technology earnings dip after IPO costs
Figure Technology Solutions confirmed an anticipated consecutive-quarter drop in earnings but reported that its numbers were up compared to a…
Read More » -
MOZAYYX Acquisition closes upsized $300M IPO
MOZAYYX Acquisition Corp (NYSE: MZYX) closed an upsized initial public offering of 30,000,000 units at…
Read More » -
Medline IPO Opens Public Scrutiny On Growth Guidance And ESOP Plans
Make better investment decisions with Simply Wall St’s easy, visual tools that give you a competitive edge. Medline (NasdaqGS:MDLN) completed…
Read More » -
Canada’s IPO market wakes up
After years in a Bay Street coma, Canada’s IPO market appears to have a pulse. What happened: Apotex, Canada’s largest…
Read More » -
HKEX profit jumps 36% to another record high on surging turnover, IPOs
Hong Kong Exchanges and Clearing (HKEX), which operates Asia’s third-largest stock exchange, reported a record-high annual profit for the second…
Read More » -
This AI Stock Has Soared 123% Since Its IPO. Is It Still a Buy for 2026?
Key Points Shares of this neocloud infrastructure provider shot up impressively following an IPO last year, but they were also…
Read More » -
How LB Rode the Brutal Capital Markets to One of 2025’s Most Successful IPOs
LB Pharma’s successful IPO story is one of timing—good and bad. After revealing in January 2025 that schizophrenia treatment LB-102…
Read More »